Hixon Zuercher LLC Buys 10,134 Shares of Amdocs Limited $DOX

Hixon Zuercher LLC grew its stake in Amdocs Limited (NASDAQ:DOX) by 31.3% in the first quarter, Holdings Channel.com reports. The institutional investor owned 42,507 shares of the technology company’s stock after buying an additional 10,134 shares during the quarter. Hixon Zuercher LLC’s holdings in Amdocs were worth $2,774,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. TABR Capital Management LLC bought a new stake in Amdocs in the fourth quarter worth $2,398,000. American Century Companies Inc. grew its stake in shares of Amdocs by 12.5% during the third quarter. American Century Companies Inc. now owns 1,649,077 shares of the technology company’s stock valued at $135,307,000 after buying an additional 183,776 shares during the last quarter. Aberdeen Group plc increased its holdings in shares of Amdocs by 13.2% in the fourth quarter. Aberdeen Group plc now owns 263,287 shares of the technology company’s stock worth $21,197,000 after buying an additional 30,723 shares during the period. Russell Investments Group Ltd. increased its holdings in shares of Amdocs by 5.6% in the third quarter. Russell Investments Group Ltd. now owns 978,940 shares of the technology company’s stock worth $80,307,000 after buying an additional 51,548 shares during the period. Finally, BNP Paribas Financial Markets lifted its stake in shares of Amdocs by 85.4% in the 4th quarter. BNP Paribas Financial Markets now owns 201,982 shares of the technology company’s stock valued at $16,262,000 after acquiring an additional 93,036 shares during the last quarter. 92.02% of the stock is owned by institutional investors.

Analysts Set New Price Targets

DOX has been the topic of several recent research reports. Stifel Nicolaus reduced their price target on Amdocs from $88.00 to $71.00 and set a “buy” rating on the stock in a research report on Thursday, May 14th. Cfra lowered Amdocs to a “sell” rating in a research note on Thursday, May 14th. Wall Street Zen lowered shares of Amdocs from a “buy” rating to a “hold” rating in a report on Saturday, May 16th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Amdocs in a research note on Friday, May 8th. Three investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Amdocs presently has a consensus rating of “Hold” and a consensus price target of $86.67.

Amdocs Trading Up 1.3%

NASDAQ DOX opened at $52.35 on Wednesday. The stock’s 50 day moving average is $61.48 and its 200 day moving average is $69.61. The firm has a market capitalization of $5.65 billion, a PE ratio of 10.47, a P/E/G ratio of 0.90 and a beta of 0.38. The company has a quick ratio of 0.98, a current ratio of 0.98 and a debt-to-equity ratio of 0.23. Amdocs Limited has a twelve month low of $49.90 and a twelve month high of $95.41.

Amdocs (NASDAQ:DOX) last issued its quarterly earnings results on Thursday, May 14th. The technology company reported $1.78 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.77 by $0.01. Amdocs had a net margin of 11.81% and a return on equity of 19.77%. The company had revenue of $1.17 billion during the quarter, compared to analysts’ expectations of $1.17 billion. During the same period last year, the company posted $1.78 EPS. Amdocs’s revenue was up 3.9% on a year-over-year basis. Research analysts forecast that Amdocs Limited will post 6.56 earnings per share for the current fiscal year.

Amdocs Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Tuesday, June 30th will be given a dividend of $0.569 per share. This represents a $2.28 dividend on an annualized basis and a yield of 4.3%. The ex-dividend date of this dividend is Tuesday, June 30th. Amdocs’s dividend payout ratio (DPR) is 45.60%.

Amdocs Profile

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.